Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization

Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization Publisher

Ghavami SB¹ ; Shahrokh S¹ ; Asadzadeh Aghdaei H¹ ; Khoramjoo SM¹ ; Farmani M¹ ; Kazemifard N¹ ; Parigi TL^{2, 3} ; Danese S^{2, 4} ; Balaii H¹ ; Sherkat G⁵ ; Ebrahimi Daryani N⁶ ; Alborzi F⁶ ; Vossoughinia H⁷ ; Zali MR¹

Show Affiliations

1. Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Department of Biomedical Sciences, Humanitas University, Milan, Italy
3. Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
4. IBD Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy
5. Medicine Faculty of Mashhad Branch, Islamic Azad University Mashhad, Mashhad, Iran
6. Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
7. Department of Gastroenterology and Hepatology, Mashhad University of Medical Sciences, Mashhad, Iran

Source: JGH Open Published:2022

Abstract

[No abstract available]

Style	Citing Format
MLA	Ghavami SB, et al.. "Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization." JGH Open, vol. 6, no. 4, 2022, pp. 266-269.
APA	Ghavami SB, Shahrokh S, Asadzadeh Aghdaei H, Khoramjoo SM, Farmani M, Kazemifard N, Parigi TL, Danese S, Balaii H, Sherkat G, Ebrahimi Daryani N, Alborzi F, Vossoughinia H, Zali MR (2022). Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization. JGH Open, 6(4), 266-269.
Chicago	Ghavami SB, Shahrokh S, Asadzadeh Aghdaei H, Khoramjoo SM, Farmani M, Kazemifard N, Parigi TL, et al.. "Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization." JGH Open 6, no. 4 (2022): 266-269.
Harvard	Ghavami SB et al. (2022) 'Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization', JGH Open, 6(4), pp. 266-269.
Vancouver	Ghavami SB, Shahrokh S, Asadzadeh Aghdaei H, Khoramjoo SM, Farmani M, Kazemifard N, et al.. Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization. JGH Open. 2022;6(4):266-269.
BibTex	@article{ author = {Ghavami SB and Shahrokh S and Asadzadeh Aghdaei H and Khoramjoo SM and Farmani M and Kazemifard N and Parigi TL and Danese S and Balaii H and Sherkat G and Ebrahimi Daryani N and Alborzi F and Vossoughinia H and Zali MR}, title = {Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization}, journal = {JGH Open}, volume = {6}, number = {4}, pages = {266-269}, year = {2022} }
RIS	TY - JOUR AU - Ghavami SB AU - Shahrokh S AU - Asadzadeh Aghdaei H AU - Khoramjoo SM AU - Farmani M AU - Kazemifard N AU - Parigi TL AU - Danese S AU - Balaii H AU - Sherkat G AU - Ebrahimi Daryani N AU - Alborzi F AU - Vossoughinia H AU - Zali MR TI - Serological Response to Sars-Cov-2 Is Attenuated in Patients With Inflammatory Bowel Disease and Can Affect Immunization JO - JGH Open VL - 6 IS - 4 SP - 266 EP - 269 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract